Description
COA-BACKED BOTANICAL INGREDIENT
Ocimum basilicum Leaf Extract
Basil Leaf Extract Powder 20:1 is presented for B2B ingredient qualification using representative batch evidence and batch-specific analytical language.
COA-Backed Specification
| Botanical identity | Ocimum basilicum |
|---|---|
| Plant part | Leaf |
| Form and colour | Fine yellow-brown powder |
| Assay | Extract ratio 20:1; result complies |
| Particle size | 98% through 80 mesh |
| Loss on drying | <=5.0%; result 3.74% |
| Ash | <=5.0%; result 3.67% |
| Representative batch | LXLL190815 |
| Manufacture date | 15 August 2019 |
| Shelf life | Two years when stored properly |
Representative values do not replace the current shipment COA.
Buyer Decision Guide
Compare this Extract ratio 20:1; result complies ratio grade by botanical identity, plant part and physical specification; the ratio is not an active-marker percentage.
- Evaluation sample typically 10-20 g
- Regular MOQ typically 1 kg
- Typical lead time 7-15 working days
How This Grade Differs
Basil Leaf Extract Powder 20:1 is qualified using botanical identity: Ocimum basilicum; plant part: Leaf; offered grade: Extract ratio 20:1; result complies. Its purchasing definition is the stated ratio grade (Extract ratio 20:1; result complies), not a guaranteed active-compound concentration.
Compare these related grades before approval:
For a substitution review, compare botanical identity, plant part, assay target, analytical method, physical form and the current offered-batch COA.
Quality and Documentation
Representative batch LXLL190815 supports the specification table above. Use the cited record for preliminary comparison and request the offered-lot COA for final technical approval.
BUYER QUALIFICATION SNAPSHOT
Basil Leaf Extract Powder 20:1: What to Match Before Ordering
This page describes a defined ingredient grade. Use the fields below to prevent substitution between raw powder, ratio extract and standardised grades. The quotation, approved specification and current shipment COA should identify the same material.
| Botanical identity | Ocimum basilicum |
|---|---|
| Plant part | Leaf |
| Assay | Extract ratio 20:1; result complies |
| Particle size | 98% through 80 mesh |
| Loss on drying | <=5.0%; result 3.74% |
| Representative batch | LXLL190815 |
Confirm botanical source and plant part.
Match ratio or assay and its test method.
Review the current offered-batch COA.
Continue with Standardized Botanical Extracts, the grade comparison guide, or the COA review checklist.
Frequently Asked Questions
What specification defines Basil Leaf Extract Powder 20:1?
For Basil Leaf Extract Powder 20:1: Extract ratio 20:1; result complies.
What source identity defines this ingredient?
For Basil Leaf Extract Powder 20:1: Match Ocimum basilicum, Leaf across the quotation, specification and offered-batch COA. The offered grade is Extract ratio 20:1; result complies; treat the ratio as a process-grade definition rather than a marker percentage.
How should the representative batch be interpreted?
For Basil Leaf Extract Powder 20:1: The page cites representative batch LXLL190815. Final approval requires the current lot's identity, specification results and relevant dates.
Can the shipment batch be documented separately?
For Basil Leaf Extract Powder 20:1: Current batch documentation should be reviewed before purchase; a representative document is useful for screening but does not release a shipment.
How should product and contaminant tests be reviewed?
For Basil Leaf Extract Powder 20:1: Do not assess Extract ratio 20:1; result complies in isolation; particle size, moisture or drying data and market-relevant safety limits can also affect acceptance.
When should MOQ be reconfirmed?
For Basil Leaf Extract Powder 20:1: Confirm MOQ and timing on the live quotation because stock position, testing, packing and destination requirements can change both.
Which customisation requests require technical review?
For Basil Leaf Extract Powder 20:1: Alternative packing or selected parameters may be considered case by case, subject to production feasibility and a revised written specification.
Reviews
There are no reviews yet.